← SynDRA
AMYGDALIN
SynDRA canonical compound SYN0011909 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CASP3 |
|---|
| Mechanism of action | Caspase activator |
|---|
All known targets
Mechanisms of action (all sources)
- Caspase activator
- TAS2R16 AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- KCNH2
- MMP1
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- MAOA
- LCK
- HTR6
- NPY1R
- HTR2C
- HTR2B
- HTR2A
- HRH2
- HRH1
- HMGCR
- HDAC6
- FYN
- FLT1
- MMP9
- NPY2R
- ESR1
- SIGMAR1
- TBXAS1
- TAS2R16
- TACR2
- TACR1
- SLCO1B3
- SLCO1B1
- SLC6A4
- SLC6A3
- SLC6A2
- PTPRC
- NR3C1
- PTGS2
- PTGS1
- PTAFR
Drug classes
- Antineoplastic Agents, Phytogenic
Cross-references
Synonyms
- D-Amygdalin
- (R)-Amygdalin
- (R)-Laenitrile
- (R)-Amygdaloside
- R-Amygdalin
- NSC 15780
- D(-)-Mandelonitrile-beta-D-gentiobioside
- D-Mandelonitrile-beta-D-glucosido-6-beta-D-glucoside
- Glucoprunasin
- CHEBI:17019
- (-)-D-mandelonitrile beta-D-gentiobioside
- CHEBI:27613
- NSC251222
- RefChem:5553
- Mandelonitrile-beta-gentiobioside
- DTXCID701326581
- NSC15780
- Amygdaloside
- MFCD00006598
- C20H27NO11
- amygdaline
- UNII-214UUQ9N0H
- MFCD00866428
- HSDB 3559
- EINECS 249-925-3
- BRN 0066856
- Amygdalin/Vitamin B17
- AMYGDALIN [MI]
- AMYGDALIN [HSDB]
- bmse000139
- AMYGDALIN [WHO-DD]
- 5-17-08-00118 (Beilstein Handbook Reference)
- MLS002473175
- SCHEMBL131406
- orb1305010
- orb3140227
- MSK1532
Look up AMYGDALIN in the interactive SynDRA portal →